We are live on ! Find out more
IGC icon

IGC Pharma
IGC

20 hedge funds and large institutions have $872K invested in IGC Pharma in 2019 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 2

707% more capital invested

Capital invested by funds: $108K → $872K (+$764K)

400% more funds holding

Funds holding: 4 → 20 (+16)

87% more call options, than puts

Call options by funds: $88K | Put options by funds: $47K

1.06% more ownership

Funds ownership: 0% → 1.06% (+1.1%)

Holders
20
Holders Change
+16
Holders Change %
+400%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
2
Reduced
–
Closed
2
Calls
$88K
Puts
$47K
Net Calls
+$41K
Net Calls Change
+$41K

Top Buyers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$148K
2
Creative Planning
Creative Planning
Kansas
+$146K
3
Goldman Sachs
Goldman Sachs
New York
+$85K
4
SB
Suntrust Banks
Georgia
+$83.3K
5
Morgan Stanley
Morgan Stanley
New York
+$68.5K

Top Sellers

Rank Fund Capital Flow
1
CFA
Carroll Financial Associates
North Carolina
-$82K

IGC Hedge Fund Activity: Q1 2019 in Review

20 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in IGC Pharma (IGC) for Q1 2019, worth a combined $872K — up 707% from $108K a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new IGC positions and 2 closed out — a net gain of 16 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Bank of Montreal, opening a new position worth an estimated $148K. The largest seller was Carroll Financial Associates, exiting entirely with an estimated $82K sold.

  • 20 institutional investors held IGC Pharma (IGC) as of Q1 2019, up from 4 in Q4 2018.
  • Funds reported $872K of IGC Pharma stock for Q1 2019, up 707% quarter-over-quarter.
  • 18 funds opened new IGC Pharma positions in Q1 2019 and 2 closed out, a net change of +16 holders.
  • The largest IGC Pharma buyer in Q1 2019 was Bank of Montreal, an estimated $148K added.
  • The largest IGC Pharma seller in Q1 2019 was Carroll Financial Associates, an estimated $82K sold.

Based on aggregated 13F filings for Q1 2019.